Enovis | ENOV - Cash And Equivalent


Enovis reported $36.39M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Alcidion AUD 11.8M 2.84M Jun/2024
Ambu A/S DKK 735M 16M Dec/2025
Amplifon EUR 237.31M 5.38M Sep/2025
Apollo Hospitals Enterprise Ltd INR 13.6B 8.5B Mar/2025
Coloplast 911M 497M Sep/2023
Convatec Group USD 64.7M 32.2M Dec/2024
Diasorin EUR 173.08M 3.51M Jun/2025
Enovis USD 36.39M 2.77M Dec/2025
Gulf Medical Proj AED 74.52M 101.52M Mar/2025
Hoya 596.39B 62.76B Sep/2025
Med Life RON 185.35M 35.79M Sep/2025
Oriola-kd EUR 107.6M 13.9M Sep/2025
Rede D'or Sao Luiz BRL 5.53B 456.83M Sep/2025
Siemens Healthineers EUR 2.37B 30M Jun/2025
Sonova Holding CHF 413.9M 134.3M Jun/2023
Supermax Corporation Bhd MYR 855.25M 11.02M Sep/2025